BRAF mutation influences hypoxia-inducible factor-1α expression levels in papillary thyroid cancer
M Zerilli(University of Palermo), Vito Rodolico(University of Palermo), Carla Giordano(University of Palermo), Francesco Cappello(University of Palermo), Giovanni Zito(Regione Campania), Daniela Cabibi(University of Palermo), Maria Pitrone(University of Palermo), Annamaria Martorana(University of Palermo)
Cited by 47
Related Papers
1,2,3‐Triazole in Heterocyclic Compounds, Endowed with Biological Activity, through 1,3‐Dipolar Cycloadditions
|European Journal of Organic Chemistry|2014|341
Targeting SARS-CoV-2 Main Protease for Treatment of COVID-19: Covalent Inhibitors Structure–Activity Relationship Insights and Evolution Perspectives
|Journal of Medicinal Chemistry|2022|139
Synthesis and antitumor properties of 2,5-bis(3′-indolyl)thiophenes: Analogues of marine alkaloid nortopsentin
|Bioorganic & Medicinal Chemistry Letters|2007|105
Isoindolo[2,1-<i>a</i>]quinoxaline Derivatives, Novel Potent Antitumor Agents with Dual Inhibition of Tubulin Polymerization and Topoisomerase I
|Journal of Medicinal Chemistry|2008|99